title: Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply.
authors.affiliation: Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
authors.forename: Willemijn J
authors.initials: WJ
authors.lastname: Jansen
authors.affiliation: Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands.
authors.forename: Rik
authors.initials: R
authors.lastname: Ossenkoppele
authors.affiliation: Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
authors.forename: Pieter Jelle
authors.initials: PJ
authors.lastname: Visser
mesh_terms: D016229:Amyloid beta-Peptides / Q000032:analysis*; D053327:Apolipoprotein E4 / Q000235:genetics*; D001921:Brain / Q000473:pathology*; D060825:Cognitive Dysfunction / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D016229:Amyloid beta-Peptides; D053327:Apolipoprotein E4